Stephen Oesterle of Medtronic, a devices firm involved in remotepatientmonitoring, thinks it a bit Orwellian for drugmakers to keep such intimate tabs on their customers.
Advances in wireless remotepatientmonitoring (RPM) are expected to have a big impact across targeted disease areas where chronic conditions are a leading cause of the readmissions problem.